Neuraxpharm Aims For Sales Of €400m By Year End

The Projected Total Represents Organic Growth Of 10%

Euro_Sign
Neuraxpharm’s presence in Europe has grown to nine countries • Source: Shutterstock

More from Earnings

More from Business